Latest News


Cardiovascular and Renal Research

Study confirms deadly risk of COVID-19 for those with heart failure .

The largest study of its kind in Australia has found patients with a history of heart failure are three times more likely to die from COVID-19. Launched last year at the outset of the pandemic, the AUS-COVID trial is investigating those who are most at risk from COVID-19 in Australia. To date, it has assessed hundreds of patients in 21 hospitals across the country. The study confirmed ea.....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

Life after cardiac arrest.

Just over two years ago, Ian Hutchinson (Hutch) was cycling with a friend on Sydney’s northern beaches, taking part in an activity he regularly enjoyed with his mate. But that morning was to have a life-changing impact, with Hutch suffering a sudden cardiac arrest midway through the ride. It was only the quick thinking of his friend Don MacKee and a group of bystanders who called triple .....
Read more

Category: Cardiovascular and Renal Research

Kolling researchers identifying COVID-19 impact on heart health.

The largest study of its type in Australia will investigate the impact of COVID-19 on younger patients with new trends emerging around the cardiac complications from the Delta strain of the virus. Launched last year, the AUS-COVID trial assessed more than 640 patients in 21 hospitals across Australia, recording cardiovascular complications. From this group, 125 were people were admitted .....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

Recognition for a remarkable career.

Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock has been recognised for her extraordinary contribution to healthcare in this year’s Queen’s birthday honour roll. Professor Pollock has been appointed an officer of the order of Australia for her distinguished service to medical research, education and science, nephrology, and clinical practice .....
Read more

Category: Awards, Cardiovascular and Renal Research, Research Excellence

Kolling researchers join global effort to reduce heart disease in women.

Two leading cardiovascular experts have been appointed to a prestigious world expert panel to reduce rates of cardiovascular disease in women. Royal North Shore Hospital (RNSH) interventional cardiologist and Kolling Institute researcher, Professor Gemma Figtree, and RNSH senior hospital scientist and Kolling Institute researcher, Dr Anastasia Mihailidou, have been appointed commissioner.....
Read more

Category: Cardiovascular and Renal Research

Researchers drive global call to action to tackle world’s leading cause of death.

A team of researchers from the Kolling Institute, The University of Sydney, Monash University and La Trobe University have led a global call to action to accelerate new approaches for cardiovascular disease (CVD) drug solutions. CVD is the leading cause of death globally. Since the start of the pandemic approximately 18 million people have died of CVD, with the majority from low- and mid.....
Read more

Category: Cardiovascular and Renal Research

Our researchers secure highly competitive national funding .

Two of our leading researchers will drive key Australian projects following a funding announcement from the National Health and Medical Research Council. (NHMRC) More than $1.4 million from the partnership grant program will go to Kolling researcher and RNSH interventional cardiologist Professor Gemma Figtree and her team for a study to reduce coronary artery disease. The world-first pro.....
Read more

Category: Cardiovascular and Renal Research

New funding supports innovative approach to diagnose heart failure.

Kolling researcher and Royal North Shore Hospital cardiologist Dr Rebecca Kozor will lead a world-first study using MRI technology to improve the diagnosis of heart failure. The trial has been made possible following a $50,000 Cardiac Society of Australia and New Zealand-Boehringer Ingelheim innovation grant. Dr Kozor has welcomed the funding to quantify pulmonary congestion or lung wate.....
Read more

Category: Cardiovascular and Renal Research, Funding support

Every week counts in the lead up to birth.

The Kolling’s Women and Babies Research team is calling for a reduction in the number of early births, with the latest research highlighting the benefits of labour as close to 40 weeks as possible. Twenty years ago, the majority of women gave birth at 40 weeks. Today it’s between 38 and 39 weeks and continuing to get earlier. This trend is due to the growing number of planned early birth.....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

Kolling researchers to drive exciting new projects following funding success .

Professor Gemma Figtree has led a successful bid for a Cardiovascular Centre of Excellence, securing $2.5 million in funding from the National Health and Medical Research Council. (NHMRC) Around 20 national and international collaborators will be involved in the research, targeting the global heart disease epidemic through new diagnostic techniques and prevention strategies. Professor Fi.....
Read more

Category: Cardiovascular and Renal Research, Funding support